Komine K - Search Results

1

Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease.

Kobayashi A, Takahashi M, Imai H, Akiyama S, Sugiyama S, Komine K, Saijo K, Takahashi M, Takahashi S, Shirota H, Sato N, Fujishima F, Shuin T, Shimodaira H, Ishioka C. Kobayashi A, et al. Among authors: komine k. Intern Med. 2016;55(6):629-34. doi: 10.2169/internalmedicine.55.5796. Epub 2016 Mar 15. Intern Med. 2016. PMID: 26984080 Free article.

2

[Status of components in EGFR-related signal transduction as predictive markers for anti-EGFR antibody therapy in colorectal cancer treatment].

Shimodaira H, Soeda H, Komine K, Ishioka C. Shimodaira H, et al. Among authors: komine k. Gan To Kagaku Ryoho. 2009 Jul;36(7):1063-6. Gan To Kagaku Ryoho. 2009. PMID: 19620792 Review. Japanese.

3

[Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody].

Shimodaira H, Komine K, Soeda H, Ishioka C. Shimodaira H, et al. Among authors: komine k. Gan To Kagaku Ryoho. 2010 May;37(5):795-8. Gan To Kagaku Ryoho. 2010. PMID: 20495309 Japanese.

4

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.

Soeda H, Shimodaira H, Watanabe M, Suzuki T, Gamoh M, Mori T, Komine K, Iwama N, Kato S, Ishioka C. Soeda H, et al. Among authors: komine k. Int J Clin Oncol. 2013 Aug;18(4):670-7. doi: 10.1007/s10147-012-0422-8. Epub 2012 May 26. Int J Clin Oncol. 2013. PMID: 22638623

5

Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer.

Otsuka K, Imai H, Soeda H, Komine K, Ishioka C, Shibata H. Otsuka K, et al. Among authors: komine k. Anticancer Res. 2013 Feb;33(2):625-9. Anticancer Res. 2013. PMID: 23393358

6

Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer.

Imai H, Soeda H, Komine K, Otsuka K, Shibata H. Imai H, et al. Among authors: komine k. BMC Palliat Care. 2013 Oct 29;12(1):38. doi: 10.1186/1472-684X-12-38. BMC Palliat Care. 2013. PMID: 24165041 Free PMC article.

7

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment.

Soeda H, Shimodaira H, Watanabe M, Suzuki T, Gamo M, Takahashi M, Komine K, Kato S, Ishioka C. Soeda H, et al. Among authors: komine k. Mol Clin Oncol. 2014 May;2(3):356-362. doi: 10.3892/mco.2014.254. Epub 2014 Feb 10. Mol Clin Oncol. 2014. PMID: 24772300 Free PMC article.

8

Functional Complementation Assay for 47 MUTYH Variants in a MutY-Disrupted Escherichia coli Strain.

Komine K, Shimodaira H, Takao M, Soeda H, Zhang X, Takahashi M, Ishioka C. Komine K, et al. Hum Mutat. 2015 Jul;36(7):704-11. doi: 10.1002/humu.22794. Hum Mutat. 2015. PMID: 25820570 Free PMC article.

9

[Points of management for elderly patients in chemotherapy].

Komine K, Ishioka C. Komine K, et al. Nihon Rinsho. 2015 Feb;73 Suppl 2:51-6. Nihon Rinsho. 2015. PMID: 25831723 Japanese. No abstract available.

10

A Curcumin Analog, GO-Y078, Effectively Inhibits Angiogenesis through Actin Disorganization.

Sugiyama S, Yoshino Y, Kuriyama S, Inoue M, Komine K, Otsuka K, Kohyama A, Yamakoshi H, Ishioka C, Tanaka M, Iwabuchi Y, Shibata H. Sugiyama S, et al. Among authors: komine k. Anticancer Agents Med Chem. 2016;16(5):633-47. doi: 10.2174/1871520615666151013125559. Anticancer Agents Med Chem. 2016. PMID: 26459768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters